| Literature DB >> 30735467 |
Jinsung Noh1, Okju Kim1,2, Yushin Jung2, Haejun Han2, Jung-Eun Kim2, Soohyun Kim3,4, Sanghyub Lee2, Jaeseong Park2, Rae Hyuck Jung5, Sang Il Kim3,4, Jaejun Park2, Jerome Han3,6, Hyunho Lee1, Duck Kyun Yoo3,6,7, Amos C Lee8, Euijin Kwon2, Taehoon Ryu2, Junho Chung3,4,6, Sunghoon Kwon1,5,8,9,10.
Abstract
In antibody discovery, in-depth analysis of an antibody library and high-throughput retrieval of clones in the library are crucial to identifying and exploiting rare clones with different properties. However, existing methods have technical limitations, such as low process throughput from the laborious cloning process and waste of the phenotypic screening capacity from unnecessary repetitive tests on the dominant clones. To overcome the limitations, we developed a new high-throughput platform for the identification and retrieval of clones in the library, TrueRepertoire™. This new platform provides highly accurate sequences of the clones with linkage information between heavy and light chains of the antibody fragment. Additionally, the physical DNA of clones can be retrieved in high throughput based on the sequence information. We validated the high accuracy of the sequences and demonstrated that there is no platform-specific bias. Moreover, the applicability of TrueRepertoire™ was demonstrated by a phage-displayed single-chain variable fragment library targeting human hepatocyte growth factor protein.Entities:
Keywords: Antibody discovery; NGS; antibody library; antibody library sequencing; clone retrieval; lead antibody; monoclonal antibody; phage display; rare clones
Mesh:
Substances:
Year: 2019 PMID: 30735467 PMCID: PMC6512904 DOI: 10.1080/19420862.2019.1571878
Source DB: PubMed Journal: MAbs ISSN: 1942-0862 Impact factor: 5.857